Table 2 Univariate Cox regression analysis for MACE.

From: The nonlinear association between lipoprotein(a) and major adverse cardiovascular events in acute coronary syndrome patients with three-vessel disease

 

HR

95% CI

P value

Age

1.024

1.016–1.031

< 0.001

Male

0.947

0.785–1.144

0.572

Smoking

0.911

0.769–1.079

0.281

Hypertension

1.388

1.122–1.716

0.003

Diabetes

1.240

1.047–1.469

0.013

Hyperlipidemia

0.905

0.762–1.075

0.255

Stroke

1.472

1.228–1.764

< 0.001

CKD

1.816

1.515–2.176

< 0.001

Antihypertensive drugs

1.258

1.061–1.493

0.008

Antidiabetic drugs

1.333

1.114–1.595

0.002

GRACE

1.011

1.008–1.013

< 0.001

Gensini

1.006

1.004–1.008

< 0.001

BMI

0.985

0.959–1.012

0.261

SBP

1.002

0.998–1.006

0.318

DBP

0.994

0.988–1.000

0.053

Heart rate

1.002

0.996–1.007

0.527

LVEF

0.988

0.981–0.995

< 0.001

FPG

1.028

1.012–1.045

0.001

HbA1c

1.087

1.022–1.156

0.008

Total cholesterol

1.004

0.936–1.077

0.907

Triglycerides

0.958

0.893–1.027

0.226

HDLC

1.269

0.916–1.758

0.152

LDLC

0.974

0.887–1.070

0.582

ApoA1

0.956

0.671–1.361

0.801

ApoB

1.171

0.817–1.680

0.390

Albumin

0.947

0.929–0.964

< 0.001

Uric acid

1.002

1.001–1.002

< 0.001

eGFR

0.991

0.988–0.993

< 0.001

Fibrinogen

1.190

1.081–1.311

< 0.001

  1. MACE, major adverse cardiovascular events; CKD, Chronic kidney disease; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; LVEF, left ventricular ejection fraction; FPG, fasting plasma glucose; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoA1, apolipoprotein A1; ApoAB, apolipoprotein B; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate; HR, hazard ratio; CI, confidence interval.
Back to article page